Govt Cracks Whip On Medical Device Makers, Importers

New Delhi : Concerned over quality and safety, the Centre has directed all manufacturers and importers of Class A medical devices to display the generic name, brand name, intended use, material of construction and shelf life of the product.

These devices, classified as non-sterile and low-risk, include catheters, disposable perfusion sets and surgical dressings among others. The Govt said this information also has to be shared on its “Online System of Medical Devices.”

Earlier, it was not mandatory for manufacturers to share the specific details with the Govt.

In the new notification, the Centre has proposed registration of Class A category medical devices, thus making these pharma products registered through an identified online portal established for this purpose.

“The manufacturers of a medical device shall upload the information such as name & address of manufacturing site, details of medical device, generic name, brand name, model number, intended use, dimension, shelf life and material of construction. Further, the manufacturers and importer shall self-certify that the product is conforming to the essential principles‘ checklist of safety and performance of such devices and comply to the standards prescribed in the medical device rules, 2017,” said the notification.

“Besides, this manufacturer or importer has to maintain the records of manufacturing/import along with its sales or distribution and should present the records before licensing authority as and when required. The licensing authorities can verify the records and documents at any point of time and investigate quality or safety related failures or complaints,” the document stated.

In India, medical devices are classified into four categories—with class A being the low-risk medical devices, class B low-moderate risk, class C moderate-high risk and Class D high-risk.

Makers of class D equipment have to follow a stringent procedure to get licenses for manufacturing.

Queries sent to health ministry spokespeople did not elicit a response.

 

  • Related Posts

    • Pharma
    • December 23, 2024
    • 79 views
    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    India’s healthcare and pharmaceutical sectors raised Rs 14,811 crore through initial public offerings (IPOs) in 2024, the largest since 2019, driven by strong domestic demand amid expanding global opportunities. According…

    • Pharma
    • December 23, 2024
    • 112 views
    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 65 new drug formulations and notified ceiling price fixation of 13 formulations. The regulatory body, under the Department of…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    India-Latin America trade and collaboration prospects discussed at Kerala University conference

    India-Latin America trade and collaboration prospects discussed at Kerala University conference

    Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

    Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

    NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

    NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

    Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt

    Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt